BioSpace News Archive

An estimated 3.1 million Canadians live with type 2 diabetes, half of whom do not achieve adequate blood sugar control

Partnership to expand on joint ExxonMobil and REG research into cellulosic biodiesel

Biohaven Pharmaceutical Holding Company Ltd. announced the U.S. Food and Drug Administration (FDA) has notified the Company that it may proceed with its clinical investigation of BHV-3241, a novel myeloperoxidase (MPO) inhibitor, which Biohaven is developing as a potential treatment for multiple system atrophy (MSA).

Peptidream announced that it has entered into a multi-program collaborative research agreement with Osaka-based Shionogi & Co., Ltd for the discovery and development of a series of blood brain barrier (BBB) penetrating peptide drug-conjugates (PDCs).

Medigus Ltd. announced today that it has filed an application under the framework of a consortium for a European grant for the development of a fluorescent colonoscope from Horizon 2020 fund.

Company introduces new technology at the American Physical Therapy Association Combined Sections Meeting January 23-26 in Washington, D.C.

First of its kind in the market, CBD Luxe inhalers guarantee precise dosing and predictable efficacy from organic-certified whole plant extracts

New Expert Panel of Advisors to Shape Nationwide Course of Action for Supporting Female Providers in Aesthetics

Ology Bioservices, Inc. announced today the appointment of vaccines and biologics manufacturing industry expert, Brandon Brega, to the position of Chief Operating Officer, effective immediately.

Magnolia Health, in collaboration with its parent company, Centene Corporation, has recognized Dr. Ken Gautier of All Children’s Clinic in Southaven, Mississippi, with a national award for clinical excellence.